Leadership
Vice-President and Pro-Vice-Chancellor (Health) (Interim)
Professor Wallace C.S. Lau, BBS, JP
MBChB (Dundee), MRCP (UK), MD (Honours) (Dundee), FHKCP, FHKAM (Medicine), FRCP (Edinburgh), FRCP (Glasgow), FRCP (London)
Email:
Biography
Chak-sing Lau is known as a pioneer for establishing and advancing rheumatology in Hong Kong, Asia and beyond. He is currently Vice-President & Pro-Vice-Chancellor (Health) (Interim) and Dean of Medicine at The University of Hong Kong. He is meanwhile Chair and Daniel CK Yu Professor in Rheumatology and Clinical Immunology of the University’s Li Ka Shing Faculty of Medicine (HKUMed).
CS Lau was Chairperson of the Department of Medicine and Chairman of the Board (2019 – 2022) of HKUMed. He was also the Chief of Service (2018 – 2022) in the Department of Medicine at Queen Mary Hospital. He presided over the Hong Kong Academy of Medicine (2016 – 2020), a statutory body for medical and dental specialist training in Hong Kong which is also a key advisory body to the HKSAR Government on health-related policies. Today, he sits on numerous strategic committees/ working groups of the Health Bureau, Hospital Authority and Department of Health. In 2023, he was appointed as a Member of the 14th National Committee of the Chinese People’s Political Consultative Conference (CPPCC) representing the health sector, and a general Member of the 14th Beijing Municipal Committee of the CPPCC on a 5-year term.
Like a true visionary, he rose to the challenge upon realising that he was one of only two clinical academics in the field of rheumatology in Hong Kong’s public healthcare sector on his return to the city in 1992. He took it upon himself to remedy the situation and in so doing he put the University and the city on the world map by building a thriving community of rheumatologists to populate our hospitals and community as well as weaving an extensive collaborative network of researchers from all around the world.
CS Lau set up the Hong Kong Arthritis & Rheumatism Foundation in 2001, the first and only local charity organisation that raises funds to support the needs of patients with rheumatic diseases. He co-founded the Asia Pacific Lupus Collaboration – a multi-national, multi-centre research collaboration in 2011. He spearheaded the development of the Region’s first treatment recommendations for rheumatoid arthritis and axial spondyloarthritis and took on the helms as President of the Asia Pacific League of Rheumatology Associations (APLAR) between 2006 and 2008.
Beyond the Asia Pacific region, he was a member of the Outcome Measures in Rheumatology (OMERACT) and an Advisory Member of the European Alliance of Associations for Rheumatology (EULAR) Congress Committee, and the Scientific Committee. In 2022, he was selected as an Honorary Member of EULAR, and elected as Member of Academia Europaea in 2023, and conferred the degree of Doctor of Science honoris causa by the University of Glasgow in 2024. CS Lau is Honorary Fellow of the American College of Physicians; the Academy of Medicine, Singapore; Singapore College of Physicians; Royal College of Physicians of Thailand; Academy of Medicine of Malaysia; the Royal College of Physicians of Ireland; and the Hong Kong Academy of Medicine.
Within HKUMed, he served as the Assistant Dean in Information Technology and Planning in 2001, and Student Affairs in 2005. In 2010, he was the Director for the Faculty’s Bau Institute of Medical and Health Services Education; and in 2013, he took on the role of Associate Dean of Teaching and Learning and was instrumental in reforming the MBBS Curriculum to incorporate a one-year enrichment experience for all medical students. Within the University, he has held various roles, such as serving as a member of the Senate and the Court. Currently, he is Chairman of the Committee on Higher Doctorates.
In his spare time, CS Lau is a keen runner. Befitting his calling, he not only heals and teaches the art of healthy mind and body, he lives, breathes and practises it every single day.
副校長(健康)(暫任)
劉澤星教授, BBS, JP
MBChB (Dundee), MRCP (UK), MD (Honours) (Dundee), FHKCP, FHKAM (Medicine), FRCP (Edinburgh), FRCP (Glasgow), FRCP (London)
電郵:
個人介紹
劉澤星教授為風濕病學先驅,致力在本港、亞洲及其他地區建立風濕病學和推動其發展。他是香港大學副校長(健康)(暫任)、香港大學李嘉誠醫學院(港大醫學院)院長、風濕及臨床免疫學講座教授暨於崇光基金教授(風濕及臨床免疫學)。
劉教授曾任港大醫學院內科學系系主任及醫學院委員會主席(2019至2022 年);並曾擔任瑪麗醫院內科部門主管(2018至 2022 年)。他亦曾擔任香港醫學專科學院主席(2016至2020年),該機構是本港醫學及牙醫專科培訓的法定機構,也是香港特別行政區政府在衞生政策上的重要諮詢機構。目前,劉教授是醫務衞生局、醫院管理局及衞生署多個策略委員會及工作小組成員。2023年,劉教授獲委任為中國人民政治協商會議第十四屆全國委員會醫藥衞生界委員(全國政協委員),及政協北京市第十四屆委員會委員。
劉教授於1992年回流香港時是香港公立醫院僅有的兩名風濕科臨床學者之一。高瞻遠矚的他迎難而上,積極建立風濕病學專家的團隊,進駐醫院和社區,並與來自世界各地的研究人員建立起廣泛的合作網絡,奠定港大及香港在風濕病學領域的國際地位。
劉教授於2001年成立香港風濕病基金會,是本港首個也是唯一透過籌款支援風濕病患者需求的慈善組織。其後於2011年共同創立亞太狼瘡合作組織(Asia Pacific Lupus Collaboration),該組織旨在推動跨地域及多中心的研究合作。劉教授曾推動制定亞太區首份類風濕性關節炎及中軸脊椎關節炎的治療建議,並於2006至2008年間擔任亞太風濕病協會聯盟(APLAR)的主席。
在亞太地區以外,劉教授曾任 Outcome Measures in Rheumatology(OMERACT)成員,以及歐洲風濕病學協會聯盟(EULAR)大會委員會和科學委員會的顧問成員。他於2022年獲選為EULAR的榮譽會員,並於2023年獲選為歐洲科學院院士,再於2024年獲蘇格蘭格拉斯哥大學授予名譽科學博士學位。此外,劉教授亦為美國內科醫學院、新加坡醫學專科學院、新加坡內科醫學院、泰國皇家內科醫學院、馬來西亞醫學專科學院、愛爾蘭皇家內科醫學院以及香港醫學專科學院的榮譽院士。
在港大醫學院,劉教授先後於2001年擔任助理院長(資訊科技與規劃),2005年擔任助理院長(學生事務)。在2010年,劉教授擔任鮑氏醫學及衞生教育研究所所長;並於2013年擔任副院長(教學),任內積極推動課程改革,包括參與籌劃「增潤學年」,豐富醫科生的學習體驗。除此之外,劉教授亦積極參與大學的其他工作,包括擔任教務委員會及校董會成員,現為高級博士學位委員會主席。
劉教授公餘熱愛跑步。與他行醫的使命一致,劉教授不僅育醫造才,救病扶危,更傳授身心健康的藝術,每一天也身體力行,活出健康。